Michael Huo
Overview
Explore the profile of Michael Huo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Burbano M, Russell R, Huo M, Welch R, Roy D, Rodrigues D
Materials (Basel)
. 2017 Aug;
7(3):1866-1879.
PMID: 28788544
The use of metal-on-metal (MoM) total hip implants has decreased recently due to reports of high failure rates and adverse local tissue reaction (ALTR). It has been hypothesized that wear...
22.
Huo M, Sahgal A, Pryor D, Redmond K, Lo S, Foote M
Surg Neurol Int
. 2017 Mar;
8:30.
PMID: 28303210
Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment option for spinal metastases with demonstrated efficacy in the upfront, postoperative, and re-treatment settings, as well as for tumor histologies considered...
23.
Huo M, Gorayski P, Pinkham M, Lehman M
Aust Fam Physician
. 2016 Nov;
45(11):805-809.
PMID: 27806449
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death in Australia. Radiotherapy plays an important role in the curative and palliative settings. Objective: This article reviews...
24.
Rizk P, Morris W, Oladeji P, Huo M
Geriatr Orthop Surg Rehabil
. 2016 May;
7(2):100-5.
PMID: 27239384
Postoperative delirium is a serious complication following hip surgery in elderly patients that can adversely affect outcomes in both hip fracture and arthroplasty surgery. Recently, the incidence of hip fracture...
25.
Eriksson B, Dahl O, Rosencher N, Clemens A, Hantel S, Feuring M, et al.
Thromb J
. 2015 Nov;
13:36.
PMID: 26578849
Background: Two phase 3 trials compared 28-35 days of treatment with oral dabigatran 220 mg or 150 mg (RE-NOVATE) or 220 mg (RE-NOVATE II) once daily with subcutaneous enoxaparin 40 ...
26.
Russell R, Brown T, Huo M, Jones R
J Knee Surg
. 2014 Feb;
27(6):501-4.
PMID: 24504637
Patient-specific instrumentation (PSI) was developed to improve the accuracy of component positioning in total knee arthroplasty (TKA). A meta-analysis of level I and level II studies was performed to determine...
27.
Eriksson B, Dahl O, Feuring M, Clemens A, Noack H, Hantel S, et al.
Thromb Res
. 2012 Jul;
130(5):818-20.
PMID: 22840686
Introduction: Three pivotal phase 3 trials have demonstrated that oral dabigatran etexilate showed similar safety and efficacy to enoxaparin 40 mg once daily (qd) for venous thromboembolism (VTE) prevention in...
28.
Lloyd E, Geller J, Iorio R, Yoon R, Huo M, Macaulay W
J Arthroplasty
. 2006 Sep;
21(6 Suppl 2):2-5.
PMID: 16950054
National orthopedic subspecialty meetings are a research forum where volumes of investigations are presented after a peer-reviewed selection process. The objective of this investigation was to determine the publication rate...